Key Points Cervical Cancer Cervical cancer is preventable through vaccination and
treatment of dysplasia identified on screening (cytologic screening, DNA testing for high-risk …

Abstract The WHO (World Health Organization) conducted an elimination of cervical cancer
program using triple pillar intervention strategy to target 90%-70%-90% of women before the …

Immune checkpoint inhibitors (ICIs) have dramatically transformed the treatment landscape
for various malignancies, achieving notable clinical outcomes across a wide range of …

Objective To evaluate tiragolumab (anti-TIGIT) and atezolizumab (anti-PD-L1) as second-or
third-line therapy for PD-L1-positive persistent/recurrent cervical cancer. Methods In the …

Cervical cancer is a major global health issue, ranking as the fourth most common cancer in
women worldwide. Depending on stage, histology, and patient factors, the standard …

Cervical cancer is preventable with screening and vaccination approaches; however,
access to these preventative measures is limited both nationally and globally and thus many …

Recently, oncolytic virus (OV) therapy has shown great promise in treating malignancies.
However, intravenous safety and inherent lack of immunity are two significant limitations in …

Cervical cancer constitutes a significant health burden for women worldwide despite being
preventable by vaccination and screening. Advanced stages of the disease are associated …

This study aims to assess the predictive value of certain markers of inflammation in patients
with locally advanced or recurrent/metastatic cervical cancer who are undergoing treatment …

Cervical cancer is primarily driven by persistent infection with high-risk human
papillomavirus (HPV) strains and remains a significant global health challenge, particularly …